Page last updated: 2024-10-25

eflornithine and Cholera Infantum

eflornithine has been researched along with Cholera Infantum in 3 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, and human leukocyte interferon (IFN-alpha) have synergistic anti-tumor activities in vivo in B 16 melanoma and in vitro against several human cancer cell lines."3.67Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients. ( Benjamin, R; Gutterman, J; Kantarjian, H; Plager, C; Quesada, J; Talpaz, M, 1986)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bespalov, VG1
Aleksandrov, VA1
Semenov, AL1
Kovan'ko, EG1
Ivanov, SD1
Abeloff, MD1
Rosen, ST1
Luk, GD1
Baylin, SB1
Zeltzman, M1
Sjoerdsma, A1
Talpaz, M1
Plager, C1
Quesada, J1
Benjamin, R1
Kantarjian, H1
Gutterman, J1

Other Studies

3 other studies available for eflornithine and Cholera Infantum

ArticleYear
[Comparative effects of difluoromethylornithine and tincture of Siberian ginseng root on radiation carcinogenesis and life span in rats].
    Advances in gerontology = Uspekhi gerontologii, 2012, Volume: 25, Issue:2

    Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Eflornithine; Eleutherococcus; Fema

2012
Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer.
    Cancer treatment reports, 1986, Volume: 70, Issue:7

    Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Colonic Neoplasms; Drug Evaluation; Eflornithine

1986
Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Eflornithine; Female; Gastrointestinal Diseases

1986